Table 4. Clinical and laboratory data for ckd patients with or without cardiovascular disease.
CKD Group 1 Patients (n=25) | CKD Group 2 +CVD Patients (n=25) | p-value | |
---|---|---|---|
IL-10 (pg/mL) | 5.68±10.12 | 26.01± 81.29 | 0.55 |
IL-13 (pg/mL) | 5.82± 12.63 | 2.69±4.65 | 0.44 |
IL-8 (pg/mL) | 498.24±446.51 | 638.72±524.67 | 0.39 |
TGF-β1(pg/mL) | 65.95±150.69 | 53.91±151.22 | 0.49 |
Values are expressed by mean ± SD. Group 1: CKD patients without cardiovascular disease. Group 2: CKD patients with cardiovascular disease. TGF-β1: transforming grow factor -β1, IL-8: interleukin-8, IL-10: interleukin-10, IL-13: interleukin-13.